用天然生物活性化合物准痕信号通路:对抗癌症的一种有希望的方法
Jia Yang1,2,3, Qihui Sun1,4, Xiaoyun Liu5
1College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Frontiers in pharmacology
|August 2, 2024
概括
自然化合物可以抑制Notch信号通路,这是瘤生长和癌症进展的关键因素. 针对这种途径为癌症治疗提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 痕信号通路对细胞功能至关重要,在各种癌症中异常激活.
- 口路径的激活及其与其他致癌路径的交叉声会增加癌症的攻击性.
- 准痕信号传输为癌症治疗提供了一个有前途的策略.
研究的目的:
- 审查在人类癌症中抑制Notch路径的天然生物活性化合物.
- 探索这些化合物的潜力,以防止诺奇与其他致癌途径的交叉通道.
- 突出Notch作为新型抗癌药物开发的治疗点.
主要方法:
- 对自然生物活性化合物和癌症中的Notch信号研究的文献综述.
- 分析自然化合物阻碍诺奇通路激活的机制.
- 检查了诺奇通路交叉在癌症进展中的作用.
主要成果:
- 几种天然生物活性化合物对癌细胞中的Notch信号产生抑制作用.
- 这些化合物可以防止Notch与其他致癌途径的交叉通话,减少癌症的攻击性.
- 自然产品为开发新的癌症疗法提供了可行的来源.
结论:
- 天然生物活性化合物在向癌症治疗的Notch途径方面显示出显著的潜力.
- 对这些化合物的进一步研究可能会导致新的治疗方案和抗癌药物.
- 诺奇通路是瘤学中具有挑战性但非常有前途的目标.
相关概念视频
Notch Signaling Pathway
4.2K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.2K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K


